RAC 2.92% $1.94 race oncology ltd

Ann: Race Initiates FTO Melanoma Preclinical Study, page-38

  1. 417 Posts.
    lightbulb Created with Sketch. 66
    Half expected a price drop after this announcement. 12 months for pre-clinical trials before human trials start in 2022 is along time for shareholders to wait around, albeit standard for biotechs. But i'm not deterred. Here for the long haul.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.